What changed in workplace drug testing for 2026?
Three currents define the 2026 employer compliance landscape: (1) federal fentanyl addition effective July 7, 2025; (2) DOT oral-fluid authorization still pending operational HHS lab certification; and (3) expanding state-law restrictions on employer cannabis testing for non-safety-sensitive roles.
What changed in 2025
The most significant federal change is SAMHSA's July 7, 2025 addition of fentanyl and norfentanyl to the authorized federal urine and oral-fluid panels. DOT-regulated employers now test for these analytes under 49 CFR Part 40 as of that effective date, with screening and confirmation cutoffs of 1 ng/mL each.
DOT's 2023 oral-fluid final rule remains in effect, authorizing oral fluid as an alternative to urine — but with implementation depending on HHS certifying laboratories to perform the testing. As of 2026, urine remains the dominant DOT-regulated specimen pending broader lab certification.
Who is DOT-regulated
DOT regulation applies to safety-sensitive employees in transportation industries: FMCSA (CDL drivers), FAA (pilots, mechanics, dispatchers, controllers), FRA (railroad), FTA (transit), PHMSA (pipeline), USCG (vessel crew). The operational rule of each DOT agency defines coverage; not every employee in a transportation industry is DOT-regulated.
If your organization has both regulated and non-regulated roles, your policy and program need to clearly distinguish the two — a common pitfall is applying DOT procedures uniformly when only part of the workforce is covered.
Choosing your panel
- DOT-regulated: Use the DOT 5-panel. Not optional.
- Most non-DOT: Standard 5-panel is the default.
- Healthcare and safety-sensitive non-DOT: 10-panel adds prescription depressants.
- Cannabis-restricted jurisdictions: Consider the 4-panel for non-safety-sensitive roles.
Specimen choice
Urine remains the workplace default and the only currently operational specimen under DOT regulation (oral fluid authorized but pending HHS lab certification). Saliva (oral fluid) is increasingly used in non-DOT contexts for reasonable-suspicion and post-accident testing where observed collection adds value. Hair is rare in DOT contexts (not federally approved) but appears in some non-DOT pre-employment programs prioritizing long lookback.
Laboratory and MRO
For DOT-regulated tests, the laboratory must be SAMHSA-certified and every non-negative must be reviewed by a qualified Medical Review Officer (MRO) . Non-DOT employers should still use a SAMHSA-certified lab and an MRO — the marginal cost is small and the defensibility benefit is large. See MRO & confirmation for process detail.
State law overlays
State and municipal cannabis-testing laws are the most rapidly evolving area of workplace drug testing. Common features: off-duty use protection, pre-employment THC testing restrictions for non-safety-sensitive roles, and safety-sensitive carve-outs. See cannabis & state law for the broader landscape.
Beyond cannabis, state laws govern reasonable-suspicion protocols, post-accident timing, random testing pool composition, and the consequences of a positive result. Verify the current rule in every state where you employ regulated and non-regulated workers.
Training requirements
- FMCSA supervisor training (Part 382.603): 1 hour on alcohol misuse + 1 hour on drug use signs/symptoms.
- Designated Employer Representative (DER) training for DOT-regulated programs.
- Substance Abuse Professional (SAP) qualification for the return-to-duty process.
- Collector training for in-house collection (alternative: use a trained third-party collection network).
Program management
Recurring monthly chores include random selection runs, supervisor training refreshes, policy review against new state laws, FMCSA Clearinghouse queries (for motor-carrier employers), and MRO program quality reviews. Build a program calendar; substance use compliance fails on neglect.
Common pitfalls
Sources & references
drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.
- 49 CFR Part 40 — Procedures for Transportation Workplace Drug and Alcohol Testing Programs
- Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine)
- Final Notice — Addition of Fentanyl and Norfentanyl to Federal Workplace Drug Testing Panels
- Procedures for Transportation Workplace Drug Testing Programs: Addition of Oral Fluid Specimen Testing